A Systematic Intelligent Optimization Framework for a Sustained-Release Formulation Design

Le résumé fourni par la source

Objectives: This study proposes a systematic strategy for optimizing sustained-release formulations using mixture experiments. Methods: Model variables were identified and screened via LASSO regression, Smoothly Clipped Absolute Deviation (SCAD), and Minimax Concave Penalty (MCP), leading to the construction of a quadratic inference function-based objective model. Using this model, three multi-objective optimization algorithms—NSGA-III, MOGWO, and NSWOA—were employed to generate a Pareto-optimal solution set. Solutions were further evaluated through the entropy weight method combined with TOPSIS to reduce subjective bias. Results: The MCP-screened model demonstrated strong fit (AIC = 19.8028, BIC = 45.2951) and suitability for optimization. Among the Pareto-optimal formulations, formulation 45, comprising HPMC K4M (38.42%), HPMC K100LV (13.51%), MgO (6.28%), lactose (17.07%), and anhydrous CaHPO4 (7.52%), exhibited superior performance, achieving cumulative release rates of 22.75%, 64.98%, and 100.23% at 2, 8, and 24 h, respectively. Compared with the original formulation, drug release was significantly improved across all time points. Conclusions: This integrated workflow effectively accounted for component interactions and repeated measurements, providing a robust and scientifically grounded approach for optimizing multi-component sustained-release formulations.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.